Cullinan Therapeutics Inc (CGEM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CGEM Annual Balance Sheets →
Examining balance sheet movements between Cullinan Therapeutics Inc and Jun 30 2025 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent334.50
Short-term Investments, Total0.00
Cash & Short-term Investments334.00
Other Current Assets0.00
Prepaid Expense, Current AS7.44
Total Current Assets341.97
Equipment/Property/Plant Net0.26
Long-term investments19.02
Other Assets, Noncurrent2.57
Operating Lease Right Of Use Asset2.44
Total Assets363.79
Liabilities
Accounts Payable, Current AC3.73
Accrued Liabilities, Current AC36.24
Other Liabilities, Current0.67
Total Current Liabilities40.63
Total Long-term Debt0.00
Due to Affiliate, Noncurrent1.41
Operating Lease Liability Current0.73
Operating Lease Liability Noncurrent1.66
Total Liabilities42.03
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,013.37
Retained Earnings / Accumulated Deficit-691.48
Accumulated Other Comprehensive Income-0.13
Other Equity-0.13
Common Stockholder's Equity321.75
Total Stockholder's Equity321.75
Liabilities & Stockholder's Equity363.79
4 historic quarters locked

Sign in to unlock the full Cullinan Therapeutics Inc balance sheet history.

About Cullinan Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-336717

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.